Lab Corp Amer Dl 10 (LAB) 시세

Phunware is a Nasdaq traded stock. NWBO is an OTC stock, and the case loss is different.
You are right that means that the court will presume manipulation of OTC stocks over Nasdaq-traded stocks.
Or will your next post be that SEC rules do not apply when a stock is OTC listed?

Although I replied to you, I really wasn't addressing your post. I agree with your comment.

An "expert witness" MAY prove the grifter lebby MISGUIDED the time-lines... won't that be interesting karma?

far side has been good recently

They are trying hard to get your shares--They know what's coming 🚀, Hold Tight & Reap the Rewards. 🚂 $$$$$$

My handlers??

I am just a tired long.

No I will not, I haven't broken any rules, but maybe you have??

$QIND closes merger deal with Nasdaq : HTOO. A HUGE win for ILUS Holdings, as their first sub prepares to uplist.

$TMKO - We started Tekumo after acquiring all the assets of Sequenza Inc. in January 2020. In June 2022, Tekumo entered into a Contribution Agreement with Balincan USA Inc. Balincan USA, Inc (OTC: BCNN) then changed its name and symbol to Tekumo, Inc., TKMO, and is an alternative reporting publicly

SGTM is dedicated to restoring the balance of nature while promoting responsible consumption. https://thesustainablegreenteam.com/sgtm-blog

Toggle.ai Integrates FOTOgpt.ai Studio into Map Dynamics, Enhancing AI Photography Capabilities for over 400 Enterprise Clients

Toronto, ON, Canada - November 21st, 2024 - Nextech3D.AI (OTCQX: NEXCF) (CSE: NTAR) (FSE: EP2), a leading Generative AI-powered 3D model content provider

UPB in da HIZZLE

It's called an EOY Shareholder letter for a reason, they just need to follow thru.

$TMKO - We play at the intersection of two major trends: the “Uber-ization” of product and service delivery, and the explosion of smart connected devices brought about by the “Internet of Things” (IoT).https://www.tekumo.com/

Morning Watch List : https://www.optionmillionaires.com/november-27th-2024-watch-list/

This should be of value to newbies:

BioElectronics’ Chairman Updates InvestorsOutlines Sales Activities, Clinical Trials, and a potential legal Action Against MundiPharma
November 14, 2024 Press Releases 0 Comments ianwar@bielcorp.com
Dear Shareholders,

It

Yikes

Do You mean when the GRIFTER lebby purposely MISGUIDED the timelines to prop up the price so INSIDERS could sell at the KNOWN expirations (plot the sells and the press releases) and he and the marcinobodi guy could receive the payoff bonuses via the UNadmiral head of the comp committee? Is that the

ReconAfrica Announces Completion of Drilling Operations on the Naingopo Exploration Well

https://reconafrica.com/news-media/news-releases/reconafrica-announces-completion-of-drilling-operations-on-the-naingopo-exploration-well


..


.

Morning azrholes 

$VVOS @ $3.30s: Microfloat. Cash rich. Recent FDA Approval of only device for Sleep Apnea. Upgraded last week to $6.00+ Valuation....New Sleep Apnea patent granted this week.
Coming off lows on elevated volume last week. ..Super tight Float. Moving up...$VVOS ripe. Should moving nicely higher

$VVOS @ $3.30s: Microfloat. Cash rich. Recent FDA Approval of only device for Sleep Apnea. Upgraded last week to $6.00+ Valuation....New Sleep Apnea patent granted this week.
Coming off lows on elevated volume last week. ..Super tight Float. Moving up...$VVOS ripe. Should moving nicely higher

SGTM’s commitment is to creating solutions that align with eco-friendly values.

per11th CircuitLaw $HCMC original✅infringement Complaint's Valid✅


We now turn to $HCMCs amended complaint, which presents an even stronger case in favor of $HCMC.
https://img.wattpad.com/3063c9cd99bde22340df84491c00af9aafb107a5/68747470733a2f2f73332e616d

$VVOS @ $3.30s: Microfloat. Cash rich. Recent FDA Approval of only device for Sleep Apnea. Upgraded last week to $6.00+ Valuation....New Sleep Apnea patent granted this week.
Coming off lows on elevated volume last week. ..Super tight Float. Moving up...$VVOS ripe. Should moving nicely higher

SYM down 30% on not good news Symbotic reduced its quarterly guidance and said it will need more time to file its annual report after identifying an error in its system revenue recognition.